Search Results

Return to List
Results 1–20 of 34
Title Date

Avoiding Inappropriate Clinical Decisions Based on False-Positive Human Chorionic Gonadotropin Test Results

Number 278

(Reaffirmed 2015)

ABSTRACT Clinically significant falsepositive human chorionic gonadotropin hCG test results are rare However some individuals have circulating factors in their serum eg heterophilic antibodies or nonactive forms of hCG that interact with the hCG antibody and cause unusual or unexpected test result...

November 2002

PDF Format

Guidelines for Diagnostic Imaging During Pregnancy

Number 299

(Replaces No. 158, September 1995, Reaffirmed 2014 )

ABSTRACT Undergoing a single diagnostic Xray procedure does not result in radiation exposure adequate to threaten the wellbeing of the developing preembryo embryo or fetus and is not an indication for therapeutic abortion When multiple diagnostic Xrays are anticipated during pregnancy imaging proc...

September 2004

PDF Format

Screening for Tay - Sachs Disease

Number 318

(Reaffirmed 2014, Replaces No. 162, November 1995)

ABSTRACT TaySachs disease TSD is a severe progressive neurologic disease that causes death in early childhood Carrier screening should be offered before pregnancy to individuals and couples at high risk including those of Ashkenazi Jewish FrenchCanadian or Cajun descent and those with a family his...

October 2005

PDF Format

Patient Testing Ethical Issues in Selection and Counseling

Number 363

(Reaffirmed 2015)

ABSTRACT Recommendations to patients about testing should be based on current medical knowledge a concern for the patients best interests and mutual consultation In addition to establishing a diagnosis testing provides opportunities to educate inform and advise The ethical principles of respect fo...

April 2007

PDF Format

Human Immunodeficiency Virus

Number 389

(Reaffirmed 2015)

ABSTRACT Because human immunodeficiency virus HIV infection often is detected through prenatal and sexually transmitted disease testing an obstetriciangynecologist may be the first health professional to provide care for a woman infected with HIV Universal testing with patient notification and rig...

December 2007

PDF Format

Preimplantation Genetic Screening for Aneuploidy

Number 430

(Reaffirmed 2014)

ABSTRACT Preimplantation genetic screening differs from preimplantation genetic diagnosis for single gene disorders and was introduced for the detection of chromosomal aneuploidy Current data does not support a recommendation for preimplantation genetic screening for aneuploidy using fluorescence ...

March 2009

PDF Format

The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding

Number 440

(Reaffirmed 2015)

ABSTRACT The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose carcinoma Women with postmenopausal bleeding may be assessed initially with either endometrial biopsy or transvaginal ultrasonography this initial evaluation does not require p...

August 2009

PDF Format

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish Ashkenazi descent Previously the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screening fo...

October 2009

PDF Format

Carrier Screening for Fragile X Syndrome

Number 469

(Reaffirmed 2014, Replaces No. 338, June 2006)

ABSTRACT Fragile X syndrome is the most common inherited form of mental retardation The syndrome occurs in approximately 1 in 3600 males and 1 in 40006000 females Approximately 1 in 250 females carry the premutation DNAbased molecular analysis is the preferred method of diagnosis for fragile X syn...

October 2010

PDF Format

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format

At-Risk Drinking and Alcohol Dependence: Obstetric and Gynecologic Implications

Number 496

(Reaffirmed 2013)

ABSTRACT Compared with men atrisk alcohol use by women has a disproportionate effect on their health and lives including reproductive function and pregnancy outcomes Obstetriciangynecologists have a key role in screening and providing brief intervention patient education and treatment referral for...

August 2011

PDF Format

Intimate Partner Violence

Number 518

ABSTRACT Intimate partner violence IPV is a significant yet preventable public health problem that affects millions of women regardless of age economic status race religion ethnicity sexual orientation or educational background Individuals who are subjected to IPV may have lifelong consequences in...

February 2012

PDF Format

Health Care for Lesbians and Bisexual Women

Number 525

(Reaffirmed 2014)

ABSTRACT Lesbians and bisexual women encounter barriers to health care that include concerns about confidentiality and disclosure discriminatory attitudes and treatment limited access to health care and health insurance and often a limited understanding as to what their health risks may be Health ...

May 2012

PDF Format

Placenta Accreta

Number 529

Reaffirmed 2014

ABSTRACT Placenta accreta is a potentially lifethreatening obstetric condition that requires a multidisciplinary approach to management The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate Women at greatest risk of placenta accreta are those w...

July 2012

PDF Format

Lead Screening During Pregnancy and Lactation

Number 533

(Reaffirmed 2014)

Abstract Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults In 2010 the Ce...

August 2012

PDF Format

Well-Woman Visit

Number 534

(Reaffirmed 2014)

Abstract The annual health assessment annual examination is a fundamental part of medical care and is valuable in promoting prevention practices recognizing risk factors for disease identifying medical problems and establishing the clinicianpatient relationship The annual health assessment should ...

August 2012

PDF Format

Reproductive Health Care for Incarcerated Women and Adolescent Females

Number 535

ABSTRACT Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the US correctional system Incarcerated women and adolescent females often come from disadvantaged environments and have high rates ...

August 2012

PDF Format

Reprocessed Single-Use Devices

Number 537

(Reaffirmed 2014)

ABSTRACT The reprocessing and reuse of singleuse instruments has become increasingly common Although there are limited data on reprocessed singleuse devices existing studies have found a significant rate of physical defects performance issues or improper decontamination There are currently no data...

October 2012

PDF Format

Tracking and Reminder Systems

Number 546

(Reaffirmed 2014, Replaces No. 461, August 2010)

ABSTRACT An accurate and effective tracking or reminder system is useful for the modern practice of obstetrics and gynecology Practices should not rely solely on the patient to complete all ordered studies and to follow up on health care provider recommendations Health care providers should encour...

December 2012

PDF Format

Solutions for Surgical Preparation of the Vagina

Number 571

(Reaffirmed 2015)

ABSTRACT Currently only povidoneiodine preparations are approved for vaginal surgicalsite antisepsis However there are compelling reasons to consider chlorhexidine gluconate solutions for offlabel use in surgical preparation of the vagina especially in women with allergies to iodine Although chlor...

September 2013

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998